Luca T. Giurgea

455 total citations
13 papers, 180 citations indexed

About

Luca T. Giurgea is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Luca T. Giurgea has authored 13 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Infectious Diseases and 2 papers in Health. Recurrent topics in Luca T. Giurgea's work include Influenza Virus Research Studies (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Respiratory viral infections research (5 papers). Luca T. Giurgea is often cited by papers focused on Influenza Virus Research Studies (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Respiratory viral infections research (5 papers). Luca T. Giurgea collaborates with scholars based in United States. Luca T. Giurgea's co-authors include Matthew J. Memoli, David M. Morens, Jeffery K. Taubenberger, Alison Han, Tasaduq Fazili, Deanna L. Kiska, Scott W. Riddell, Waleed Javaid, John C. Kash and Adriana Cervantes-Medina and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Infectious Diseases and mBio.

In The Last Decade

Luca T. Giurgea

13 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca T. Giurgea United States 8 96 87 39 38 33 13 180
Natalie Dailey Garnes United States 9 114 1.2× 85 1.0× 38 1.0× 20 0.5× 33 1.0× 19 235
Cyril Jean‐Marie Martel Denmark 8 126 1.3× 60 0.7× 7 0.2× 32 0.8× 49 1.5× 22 217
Waleed Aljabr Saudi Arabia 9 90 0.9× 85 1.0× 20 0.5× 30 0.8× 21 0.6× 20 195
Moses Egesa Uganda 10 68 0.7× 132 1.5× 33 0.8× 23 0.6× 57 1.7× 23 226
Hitt Sharma India 10 116 1.2× 65 0.7× 13 0.3× 14 0.4× 39 1.2× 28 206
Valentino Tisa Italy 6 148 1.5× 41 0.5× 10 0.3× 17 0.4× 19 0.6× 9 187
Barnaby Flower United Kingdom 7 80 0.8× 178 2.0× 14 0.4× 13 0.3× 13 0.4× 11 240
Cynthia Y. Tang United States 8 50 0.5× 129 1.5× 29 0.7× 28 0.7× 14 0.4× 23 223
Л. В. Колобухина Russia 7 72 0.8× 96 1.1× 14 0.4× 16 0.4× 12 0.4× 26 184
Malin Bengnér Sweden 7 140 1.5× 61 0.7× 27 0.7× 15 0.4× 94 2.8× 14 281

Countries citing papers authored by Luca T. Giurgea

Since Specialization
Citations

This map shows the geographic impact of Luca T. Giurgea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca T. Giurgea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca T. Giurgea more than expected).

Fields of papers citing papers by Luca T. Giurgea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca T. Giurgea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca T. Giurgea. The network helps show where Luca T. Giurgea may publish in the future.

Co-authorship network of co-authors of Luca T. Giurgea

This figure shows the co-authorship network connecting the top 25 collaborators of Luca T. Giurgea. A scholar is included among the top collaborators of Luca T. Giurgea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca T. Giurgea. Luca T. Giurgea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Giurgea, Luca T., Alison Han, Lindsay Czajkowski, et al.. (2025). 593. Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations
2.
Giurgea, Luca T., Alison Han, Lindsay Czajkowski, et al.. (2024). Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers. mBio. 15(2). e0237223–e0237223. 9 indexed citations
3.
Giurgea, Luca T. & David M. Morens. (2022). Great Expectations of COVID-19 Herd Immunity. mBio. 13(1). e0349521–e0349521. 12 indexed citations
4.
Giurgea, Luca T., Jae-Keun Park, Kathie‐Anne Walters, et al.. (2021). The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine. npj Vaccines. 6(1). 48–48. 8 indexed citations
5.
Giurgea, Luca T., Adriana Cervantes-Medina, Kathie‐Anne Walters, et al.. (2021). Sex Differences in Influenza: The Challenge Study Experience. The Journal of Infectious Diseases. 225(4). 715–722. 28 indexed citations
6.
Giurgea, Luca T., Alison Han, & Matthew J. Memoli. (2020). Universal coronavirus vaccines: the time to start is now. npj Vaccines. 5(1). 43–43. 29 indexed citations
7.
Giurgea, Luca T., David M. Morens, Jeffery K. Taubenberger, & Matthew J. Memoli. (2020). Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine. Vaccines. 8(3). 409–409. 39 indexed citations
8.
Giurgea, Luca T., Adriana Cervantes-Medina, Alison Han, et al.. (2020). 1524. Sex Differences in Influenza: The Challenge Study Experience. Open Forum Infectious Diseases. 7(Supplement_1). S764–S764. 2 indexed citations
9.
Giurgea, Luca T. & Matthew J. Memoli. (2020). Navigating the Quagmire: Comparison and Interpretation of COVID-19 Vaccine Phase 1/2 Clinical Trials. Vaccines. 8(4). 746–746. 4 indexed citations
10.
Shelton, Andrew, et al.. (2019). A Case of Mycobacterium goodii Infection Related to an Indwelling Catheter Placed for the Treatment of Chronic Symptoms Attributed to Lyme Disease. Infectious Disease Reports. 11(2). 8108–8108. 8 indexed citations
11.
Han, Alison, Luca T. Giurgea, Adriana Cervantes-Medina, et al.. (2019). 2750. Sequential Influenza A H1N1 and Influenza A H3N2 Challenge Infections in Healthy Volunteers. Open Forum Infectious Diseases. 6(Supplement_2). S969–S969. 1 indexed citations
12.
Fazili, Tasaduq, et al.. (2017). Streptococcus anginosus Group Bacterial Infections. The American Journal of the Medical Sciences. 354(3). 257–261. 35 indexed citations
13.
Giurgea, Luca T., et al.. (2016). Haemophilus parainfluenzaeMural Endocarditis: Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2016. 1–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalie Dailey Garnes Breakdown of academic impact, for papers by Cyril Jean‐Marie Martel Breakdown of academic impact, for papers by Waleed Aljabr Breakdown of academic impact, for papers by Moses Egesa Breakdown of academic impact, for papers by Hitt Sharma Breakdown of academic impact, for papers by Valentino Tisa Breakdown of academic impact, for papers by Barnaby Flower Breakdown of academic impact, for papers by Cynthia Y. Tang Breakdown of academic impact, for papers by Л. В. Колобухина Breakdown of academic impact, for papers by Malin Bengnér
Rankless by CCL
2026